Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite

Journal of Pharmacology and Experimental Therapeutics

Volumn 251, Issue 2, 1989, Pages 477-483

  Paul, D ^a   Standifer, K M ^a   Inturrisi, C E ^a   Pasternak, G W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ENKEPHALIN DERIVATIVE; MORPHINE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; RADIOISOTOPE; RECEPTOR SUBTYPE;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; GASTROINTESTINAL MOTILITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

ANALGESIA; ANIMAL; DRUG TOLERANCE; GASTROINTESTINAL MOTILITY; MALE; MICE; MORPHINE; MORPHINE DERIVATIVES; NALOXONE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024369341     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)